https://news.medxy.ai/comparative-1-year-outcomes-of-semaglutide-tirzepatide-and-sleeve-gastrectomy-in-obese-adults-with-type-2-diabetes-insights-from-real-world-data/Medxy AIen2026-06-20T09:52:42-07:00Comparative 1-Year Outcomes of Semaglutide, Tirzepatide, and Sleeve Gastrectomy in Obese Adults with Type 2 Diabetes: Insights from Real-World Data https://news.medxy.ai/zh/%e6%8f%ad%e5%bc%80%e6%9c%aa%e5%88%86%e7%b1%bb%e8%82%ba%e5%8a%a8%e8%84%89%e9%ab%98%e5%8e%8b%e7%9a%84%e8%a1%a8%e5%9e%8b%ef%bc%9a%e9%9a%90%e8%97%8f%e7%9a%84%e5%b0%84%e8%a1%80%e5%88%86%e6%95%b0%e4%bf%9d/Medxy AIzh2026-06-20T09:43:47-07:00揭开未分类肺动脉高压的表型：隐藏的射血分数保留性心力衰竭早期谱系 https://news.medxy.ai/ja/%e9%9d%9e%e5%88%86%e9%a1%9e%e6%80%a7%e8%82%ba%e9%ab%98%e8%a1%80%e5%9c%a7%e7%97%87%e3%81%ae%e8%a1%a8%e7%8f%be%e5%9e%8b%e3%82%92%e8%a7%a3%e3%81%8d%e6%98%8e%e3%81%8b%e3%81%99%e2%80%95%e2%80%95%e6%97%a9/Medxy AIja2026-06-20T09:43:29-07:00非分類性肺高血圧症の表現型を解き明かす――早期HFpEFが潜む多様なスペクトラム https://news.medxy.ai/vi/lam-sang-to-kieu-hinh-cua-tang-ap-dong-mach-phoi-khong-phan-loai-mot-pho-tiem-an-cua-suy-tim-phan-suat-tong-mau-bao-ton-giai-doan-som/Medxy AIvi2026-06-20T09:43:09-07:00Làm sáng tỏ kiểu hình của tăng áp động mạch phổi không phân loại: một phổ tiềm ẩn của suy tim phân suất tống máu bảo tồn giai đoạn sớm https://news.medxy.ai/unveiling-the-phenotype-of-unclassified-pulmonary-hypertension-a-hidden-spectrum-of-early-heart-failure-with-preserved-ejection-fraction/Medxy AIen2026-06-20T09:41:36-07:00Unveiling the Phenotype of Unclassified Pulmonary Hypertension: A Hidden Spectrum of Early Heart Failure with Preserved Ejection Fraction https://news.medxy.ai/ja/%e5%bf%83%e4%b8%8d%e5%85%a8%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%ad%bb%e4%ba%a1%e6%a7%98%e5%bc%8f%e5%89%8d%e3%81%ae%e3%83%90%e3%82%a4%e3%82%aa%e3%83%9e%e3%83%bc%e3%82%ab%e3%83%bc%e3%83%bb%e6%a9%9f/Medxy AIja2026-06-20T09:40:35-07:00心不全における死亡様式前のバイオマーカー・機能状態・QOLの推移：FINEARTS-HFランダム化臨床試験の事後解析 https://news.medxy.ai/vi/biomarker-tinh-trang-chuc-nang-va-dien-tien-chat-luong-cuoc-song-truoc-cac-kieu-tu-vong-o-suy-tim-phan-tich-hau-kiem-thu-nghiem-lam-sang-ngau-nhien-finearts-hf/Medxy AIvi2026-06-20T09:40:19-07:00Biomarker, tình trạng chức năng và diễn tiến chất lượng cuộc sống trước các kiểu tử vong ở suy tim: Phân tích hậu kiểm thử nghiệm lâm sàng ngẫu nhiên FINEARTS-HF https://news.medxy.ai/biomarker-functional-status-and-quality-of-life-trajectories-before-modes-of-death-in-heart-failure-post-hoc-analysis-of-the-finearts-hf-randomized-clinical-trial/Medxy AIen2026-06-20T09:38:52-07:00Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial https://news.medxy.ai/vi/giai-ma-dot-bien-slc4a3-trong-hoi-chung-qt-ngan-goc-nhin-tu-te-bao-co-tim-biet-hoa-tu-hipsc-ve-loan-nhip-that-va-dot-tu-do-tim/Medxy AIvi2026-06-20T09:35:30-07:00Giải mã đột biến SLC4A3 trong hội chứng QT ngắn: góc nhìn từ tế bào cơ tim biệt hóa từ hiPSC về loạn nhịp thất và đột tử do tim https://news.medxy.ai/decoding-slc4a3-mutations-in-short-qt-syndrome-insights-from-hipsc-derived-cardiomyocytes-into-ventricular-arrhythmia-and-sudden-cardiac-death/Medxy AIen2026-06-20T09:34:13-07:00Decoding SLC4A3 Mutations in Short QT Syndrome: Insights from hiPSC-Derived Cardiomyocytes into Ventricular Arrhythmia and Sudden Cardiac Death https://news.medxy.ai/zh/sapien-3-tavr%e4%b8%8e%e6%89%8b%e6%9c%af%e6%b2%bb%e7%96%97%e4%b8%ad%e5%8d%b1%e4%b8%bb%e5%8a%a8%e8%84%89%e7%93%a3%e7%8b%ad%e7%aa%84%e6%82%a3%e8%80%85%ef%bc%9a10%e5%b9%b4%e7%bb%93%e5%b1%80%e5%af%b9/Medxy AIzh2026-06-20T09:32:03-07:00SAPIEN 3 TAVR与手术治疗中危主动脉瓣狭窄患者：10年结局对比 https://news.medxy.ai/ja/%e4%b8%ad%e7%ad%89%e3%83%aa%e3%82%b9%e3%82%af%e3%81%ae%e5%a4%a7%e5%8b%95%e8%84%88%e5%bc%81%e7%8b%ad%e7%aa%84%e7%97%87%e6%82%a3%e8%80%85%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8bsapien-3-tavr%e3%81%a8/Medxy AIja2026-06-20T09:31:46-07:00中等リスクの大動脈弁狭窄症患者におけるSAPIEN 3 TAVRと外科手術の10年成績 https://news.medxy.ai/vi/ket-cuc-sau-10-nam-cua-tavr-sapien-3-so-voi-phau-thuat-o-benh-nhan-hep-van-dong-mach-chu-nguy-co-trung-binh/Medxy AIvi2026-06-20T09:31:26-07:00Kết cục sau 10 năm của TAVR SAPIEN 3 so với phẫu thuật ở bệnh nhân hẹp van động mạch chủ nguy cơ trung bình https://news.medxy.ai/decade-long-outcomes-of-sapien-3-tavr-vs-surgery-in-intermediate-risk-aortic-stenosis-patients/Medxy AIen2026-06-20T09:30:15-07:00Decade-Long Outcomes of SAPIEN 3 TAVR vs. Surgery in Intermediate-Risk Aortic Stenosis Patients